Ubs Global Asset Management Americas »

Ionis Pharmaceuticals shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Ionis Pharmaceuticals shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $527k 500k 1.05
2023-09-30 $489k 500k 0.98

More positions owned by Ubs Global Asset Management Americas

Microsoft Corp Equity Us Cm (MSFT)
Apple Equity Us Cm (AAPL)
Amazon Equity Us Cm (AMZN)
Nvidia Corp Equity Us Cm (NVDA)
Alphabet Inc Cl A Equity Us Cm (GOOGL)
Tesla Equity Us Cm (TSLA)
Meta Platforms Equity Us Cm (META)
Alphabet Inc Cl C Equity Us Cm (GOOG)
Unitedhealth Group Equity Us Cm (UNH)
Broadcom Equity Us Cm (AVGO)
Adobe Equity Us Cm (ADBE)
Eli Lilly &#38 Equity Us Cm (LLY)
Visa Inc Class A Shares Equity Us Cm (V)
Home Depot Equity Us Cm (HD)
Johnson &#38 Johnson Equity Us Cm (JNJ)

View all positions for Ubs Global Asset Management Americas

Top funds holding Ionis Pharmaceuticals

Steelhead Partners
Citadel Advisors
Lazard Asset Management
Tenor Capital Management
CSS
MacKay Shields
Capstone Investment Advisors
Wolverine Asset Management
Wells Fargo & Company
DeepCurrents Investment Group
Calamos Advisors
Bnp Paribas Arbitrage, Snc
Aviva
Shenkman Capital Management
Deutsche Bank Aktiengesellschaft

View all funds holding Ionis Pharmaceuticals